Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion type Assertion NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_head.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion description "[While the common APOE polymorphism explains the majority of the locus genetic determinants of plasma lipid levels, additional SNPs in the APOC1/C2 region may contribute to CHD risk, but these effects require confirmation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_provenance.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion evidence source_evidence_literature NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_provenance.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion SIO_000772 20498921 NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_provenance.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion wasDerivedFrom befree-2016 NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_provenance.
- NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_assertion wasGeneratedBy ECO_0000203 NP814348.RAv5BMkwmYbrN3O1VjgUfLnJG_BuEi5u7wonOOFo6Cagg130_provenance.